Artificial intelligence biosensors for continuous glucose monitoring

X Jin, A Cai, T Xu, X Zhang - Interdisciplinary Materials, 2023 - Wiley Online Library
Artificial intelligence (AI) algorithms in combination with continuous monitoring technologies
have the potential to revolutionize chronic disease management. The recent innovations in …

Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era

AAS Akil, E Yassin, A Al-Maraghi, E Aliyev… - Journal of translational …, 2021 - Springer
Type 1 diabetes affects millions of people globally and requires careful management to
avoid serious long-term complications, including heart and kidney disease, stroke, and loss …

[HTML][HTML] Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention

A Nakhleh, N Shehadeh - World journal of diabetes, 2021 - ncbi.nlm.nih.gov
Hypoglycemia is a common complication in patients with diabetes, mainly in those treated
with insulin, sulfonylurea, or glinide. Impairments in counterregulatory responses and …

Stem cell-based clinical trials for diabetes mellitus

E De Klerk, M Hebrok - Frontiers in endocrinology, 2021 - frontiersin.org
Since its introduction more than twenty years ago, intraportal allogeneic cadaveric islet
transplantation has been shown to be a promising therapy for patients with Type I Diabetes …

Therapies for type 1 diabetes: current scenario and future perspectives

V Pathak, NM Pathak, CL O'Neill… - Clinical Medicine …, 2019 - journals.sagepub.com
Type 1 diabetes (T1D) is caused by autoimmune destruction of insulin-producing β cells
located in the endocrine pancreas in areas known as islets of Langerhans. The current …

Wearable glucose monitoring and implantable drug delivery systems for diabetes management

J Zhang, J Xu, J Lim, JK Nolan, H Lee… - Advanced Healthcare …, 2021 - Wiley Online Library
The global cost of diabetes care exceeds 1trillioneachyearwithmorethan 327 billion being
spent in the United States alone. Despite some of the advances in diabetes care including …

'Smart'insulin-delivery technologies and intrinsic glucose-responsive insulin analogues

MA Jarosinski, B Dhayalan, N Rege, D Chatterjee… - Diabetologia, 2021 - Springer
Insulin replacement therapy for diabetes mellitus seeks to minimise excursions in blood
glucose concentration above or below the therapeutic range (hyper-or hypoglycaemia). To …

Do-it-yourself artificial pancreas systems: a review of the emerging evidence and insights for healthcare professionals

P Jennings, S Hussain - Journal of Diabetes Science and …, 2020 - journals.sagepub.com
Application of artificial pancreas systems in type 1 diabetes (T1D) represents a change in
approach to managing complex glucose and insulin dynamics using automated features …

Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy

J Fuchs, R Hovorka - Expert review of medical devices, 2020 - Taylor & Francis
Introduction Type 1 diabetes is a lifelong disease with high management burden. The
majority of people with type 1 diabetes fail to achieve glycemic targets. Algorithm-driven …

[HTML][HTML] Experiences of young people and their caregivers of using technology to manage type 1 diabetes mellitus: systematic literature review and narrative synthesis

N Brew-Sam, M Chhabra, A Parkinson, K Hannan… - JMIR …, 2021 - diabetes.jmir.org
Background: In the last decade, diabetes management has begun to transition to technology-
based care, with young people being the focus of many technological advances. Yet …